Article
Cell‐free DNA as a biomarker after lung transplantation: A proof‐of‐concept study
19 Apr 2022
Abstract excerpt
BACKGROUND: Lung transplantation (LTx) is a lifesaving procedure burdened with limited long-term survival. The most common cause of death after LTx is chronic lung allograft dysfunction (CLAD). Today, useful biomarkers for the detection of CLAD are lacking. Circulating cell-free DNA (cfDNA) is released during cellular decay and can be detected using polymerase chain reaction (PCR). Thus, donor-derived cfDNA in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
